Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
for
Small Cell Lung Cancer, SCLC,
Location: Charlottesville VA, Detroit MI, Indianapolis IN,
Sponsor: Hirva Mamdani
Sex: All
Age: 18+
Code: NCT05903092
Phase 2, Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
for
Heart Failure
Location: Quebec, Winchester, Ottawa, Camp Hill PA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 40 - 70+
Code: NCT06979362
Phase 2, Recruiting
Study of AUBE00 in Patients With Solid Tumors
for
Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Houston TX
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18+
Code: NCT07030959
Phase 1, Recruiting
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
for
Ovarian Cancer Recurrent, Ovarian Cancer,
Location: Buffalo NY, Detroit MI, Minneapolis MN, Houston TX
Sponsor: Outpace Bio, Inc.
Sex: Female
Age: 18+
Code: NCT07030907
Phase 1, Recruiting
NeuroTrainer Cognitive Training For Academic Focus